Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
★★★★★
☆☆☆☆☆
Hire Dr. Sharon O.
Ireland
Profile Summary
Subject Matter Expertise
Services
Work Experience

Research Assistant - Research Associate

Duke-NUS Graduate Medical School, Singapore

October 2007 - October 2012

Technical Specialist

Abbott Ireland Diagnostics Division, Longford, Ireland

September 2005 - July 2007

R&D Scientist

Trinity Biotech Plc., Bray, Co. Wicklow, Ireland

May 2004 - September 2005

Education

PhD (pending)

University College Dublin

January 2013 - Present

MSc

University Of Notre Dame, IN, USA

August 2001 - August 2004

BSc (Hons)

University College Dublin, Ireland

September 1997 - May 2001

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
O'Neill, S., Brault, J., Stasia, M. J., Knaus, U. G.(2015). Genetic disorders coupled to ROS deficiency . Redox Biol. 6. p. 135-56.
Jacobsen, J. P., Plenge, P., Sachs, B. D., Pehrson, A. L., Cajina, M., Du, Y., Roberts, W., Rudder, M. L., Dalvi, P., Robinson, T. J., et al.(2014). The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse . Psychopharmacology (Berl). 231. (23). p. 4527-40.
Ng, C. H., Guan, M. S., Koh, C., Ouyang, X., Yu, F., Tan, E. K., O'Neill, S. P., Zhang, X., Chung, J., Lim, K. L.(2012). AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease . J Neurosci. 32. (41). p. 14311-7.
Flanagan, L., Packman, K., Juba, B., O'Neill, S., Tenniswood, M., Welsh, J.(2003). Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion. J Steroid Biochem Mol Biol. 84. (2-3). p. 181-92.